PRODUCT DETAIL

Retrovir 250 mg

Code

14102

MA number

59/0151/88-CS

Product Form:

cps dur 40x250 mg (blis.PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

National

Therapeutic Class:

59 - IMMUNOPRAEPARATA

ATC:

J	ANTIINFECTIVES FOR SYSTEMIC USE
J05	ANTIVIRALS FOR SYSTEMIC USE
J05A	DIRECT ACTING ANTIVIRALS
J05AF	Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF01	Zidovudine

Shelf life:

Container:

blister PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 8(3) application - new active substance
MA issued:	24.08.1988
Pediatric indication:	Yes
Pediatric posology:	Yes
PIL:	PIL_Retrovir 100 mg_250 mg_10.2022.pdf
SPC:	SPC_Retrovir 100 mg_250 mg_10.2022.pdf
Safety feature	Yes
Data update:	05.10.2022